Skandinaviska Enskilda Banken (SEB)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-92
| Closed | -$14K | – | 946 |
|
|
2022
Q3 | $14K | Sell |
92
-52,454
| -100% | -$7.98M | ﹤0.01% | 875 |
|
|
2022
Q2 | $7.66M | Sell |
52,546
-78,640
| -60% | -$11.5M | 0.06% | 287 |
|
|
2022
Q1 | $15.6M | Sell |
131,186
-23,914
| -15% | -$2.84M | 0.09% | 206 |
|
|
2021
Q4 | $21.4M | Sell |
155,100
-19,318
| -11% | -$2.67M | 0.11% | 169 |
|
|
2021
Q3 | $24.2M | Sell |
174,418
-3,075
| -2% | -$427K | 0.13% | 157 |
|
|
2021
Q2 | $17.2M | Buy |
177,493
+57,957
| +48% | +$5.63M | 0.11% | 192 |
|
|
2021
Q1 | $8.17M | Buy |
+119,536
| New | +$8.17M | 0.05% | 306 |
|